In the period from May till June, 2010, in the Far East and Caucasus, a large-scale program involving audit of pharmaceutical institutions (PI) took place. The program covered a total of 600 PIs.

The whole assortment of drugs produced by “Novartis” company was analyzed in points of sales included in the address program. The auditors were also monitoring new points of sales to further attract those to cooperation in frames of audit and motivation programs.

In September, 2010, the second phase of analysis was carried out in the following regions: Yakutia, Caucasus and the Far East. A total of 800 PIs were covered.